Introduction
The human hydroxysteroid sulfotransferase enzyme, recently designated under a proposed standardized nomenclature as (HUMAN)SULT2A1 (Blanchard et al., 2004) , catalyzes the transfer of a sulfonyl moiety from the physiological sulfate donor, 3'-phosphoadenosine-5'-phosphosulfate, to a variety of endogenous and exogenous substrates, including α -hydroxysteroid hormones, β -hydroxysteroids such as the androgen precursor dehydroepiandrosterone, bile acids, benzylic alcohol procarcinogens, and other hormonal and xenobiotic substrates (Glatt et al., 1995; Falany et al., 1995) . Sulfonation generally produces stable and relatively polar conjugates that are recognized and eliminated from the cell (detoxication) through the facilitated action of ATPbinding cassette membrane transporters expressed on the canalicular membranes of hepatocytes (Chu et al., 2004) . However, the generation of unstable sulfonate esters represents a clear risk factor for mutagenesis (intoxication). For example, recombinant (HUMAN)SULT2A1 is capable of bioactivating hydroxymethyl polycyclic aromatic hydrocarbons (Falany et al., 1995) and benzylic alcohol procarcinogens (Glatt et al., 1995) to reactive DNA-damaging species.
(HUMAN)SULT2A1 is most abundantly expressed in the liver, but is also expressed in other metabolically active tissues, such as the intestine and adrenal gland (Falany et al., 1995; Chen et al., 2003) . The elevated levels of (HUMAN)SULT2A1 in the developing fetal adrenal gland underscore the involvement of (HUMAN)SULT2A1 in early steroidogenesis (Rehman et al., 2003) . Unlike the rat, which expresses three known hepatic SULT2A family members (Yamazoe et al., 1994) , humans express one major SULT2A enzyme (Falany et al., 1995) . This article has not been copyedited and formatted. The final version may differ from this version. Increasing evidence indicates that the SULT2A enzymes play a pivotal role in the maintenance of hepatic bile acid homeostasis. In concert with abnormalities of sex hormone metabolism, significant aberrations in bile acid hydroxylation and sulfonation occur as clinical hallmarks of pregnancy-associated intrahepatic cholestasis, and are believed to contribute to disease progression (Reyes and Sjovall, 2000) . In addition to serving as end-products of cholesterol catabolism, bile acids are now appreciated for their important roles in cellular signaling. In the rat, the expression of hepatic A bile acid sulfotransferase@ or (RAT)SULT2A3 (Blanchard et al., 2004) is regulated by bile acid-activated members of the nuclear receptor superfamily. Primary bile acids, such as chenodeoxycholic acid and cholic acid, and their respective taurine and glycine conjugates, have been revealed as functional ligands for the hepatic FXR 1 transcription factor (Wang et al., 1999) . The hepatic accumulation of the secondary bile acid, LCA, which is formed in the small intestine through microflora-catalyzed 7α-dehydroxylation of chenodeoxycholic acid, can cause cholestasis (Staudinger et al., 2001 ).
However, activation of the PXR by LCA (Staudinger et al., 2001 ) triggers a defensive adaptation that includes increased SULT2A-mediated sulfonation, which facilitates the elimination of LCA.
The transcription of (RAT)SULT2A3 reporter genes can be activated by both the FXR (Song et al., 2001 ) and the PXR (Runge- Morris et al., 1999; Sonoda et al., 2002) transcription factors, supporting the concept that SULT2A enzyme activity plays an important physiological role in the maintenance of normal hepatic bile acid homeostasis.
The PPARs constitute another major class of nuclear receptors that function in the regulation of hepatic lipid metabolism. Thus, in the hepatocyte, PPARα is well known to regulate This article has not been copyedited and formatted. The final version may differ from this version. PPARα activation has been reported to cause up-regulation of murine bile acid-CoA thioesterase activity and protein content, with simultaneous suppression of peroxisomal bile acid-CoA:amino acid N-acyltransferase activity, thereby favoring the accumulation of hepatotoxic unconjugated bile acids (Solass et al., 2004) . PPARα has also been implicated as a positive regulator of hepatic murine multidrug resistance transporter 2 expression and associated increases in bile flow (Gbaguidi and Agellon, 2004) , as well as of human UGT2B4 and murine UGT2B, enzymes that catalyze the glucuronidation and detoxification of bile acids (Barbier et al., 2003) .
Therefore, in view of the evidence that both SULT2A and PPARα play important roles in the control of hepatic bile acid homeostasis, the present study was designed to test the hypothesis that the hepatic (HUMAN 
Materials and Methods
Primary cultured rat and human hepatocytes. Rat hepatocytes (male Sprague Dawley) were prepared, plated onto 60 mm dishes coated with 1.5 mg Matrigel, and maintained in supplemented
Williams= Medium E, as described previously (Runge- Morris et al., 1996) . Primary cultured human hepatocyte preparations were obtained from the Liver Tissue Procurement and Distribution System (LTPADS) of the University of Minnesota, in collaboration with Dr. Stephen Strom (University of Pittsburgh), and maintained as previously described (Kocarek et al., 2002) .
Northern blot, western blot, and enzyme activity analyses. The cDNA probes for rat SULT2A
(Runge- Morris et al., 1996) and (HUMAN)SULT2A1 (Duanmu et al., 2002) were prepared as previously described. Since there is one known human SULT2A family member, the cDNA probe specifically detects (HUMAN)SULT2A1 mRNA content on northern blots. The rat SULT2A cDNA probe is expected to cross-react with all rat SULT2A mRNAs. A CYP4A1 cDNA, which cross-reacts with multiple rat CYP4A subfamily mRNAs, has been described previously (Shenoy et al., 2004) . Total RNA was prepared from primary cultured rat and human hepatocytes using
Trizol reagent (Invitrogen Corporation, Carlsbad, CA). Samples of total RNA were fractionated on denaturing agarose gels, transferred onto nylon filters and hybridized with 32 P-labeled cDNA probes (Runge- Morris et al., 1996) . In order to normalize northern blots for subtle differences in RNA loading and transfer, filters were stripped of radio-labeled probe following autoradiography and re-hybridized with a 32 P-labeled 7S cDNA probe. The autoradiographs for northern blots were This article has not been copyedited and formatted. The final version may differ from this version. For measurement of cytosolic SULT2A enzymatic activity, human hepatocytes (8 T25s per treatment group) were harvested, as described above. The cell pellets were homogenized by sonication in buffer (50 µ l per flask of hepatocytes) consisting of 50mM Tris-HCl, 10% glycerol and 1.5 mM dithiothreitol, pH 7.4. Homogenates were centrifuged at 20,000xg at 4EC for 20 min, and supernatants were centrifuged at 105,000xg at 4EC for 1 hr. SULT2A enzyme activities were measured in the cytosolic fractions, as previously described (Falany et al., 1989) .
This article has not been copyedited and formatted. The final version may differ from this version. Preparation of (HUMAN)SULT2A1 reporter plasmids. A luciferase reporter plasmid containing 1463 nt of the (HUMAN)SULT2A1 5'-flanking region has been described previously (Duanmu et al., 2002) . The (HUMAN)SULT2A1 region corresponding to nt -492 to +48 was amplified by PCR, using the aforementioned plasmid as template, and ligated into the Mlu I and The product was digested with Kpn I and Mlu I and ligated into the corresponding sites of the (HUMAN)SULT2A1 promoter-luciferase reporter plasmid. For two copies, two PCR reactions were performed, one set using the Kpn I-forward primer and the EcoR I-reverse primer, and the second set using the EcoR I-forward primer and the Mlu I reverse primer. The individual products were digested with EcoR I, ligated together, digested with Kpn I and Mlu I, and ligated into the reporter plasmid. For three copies, three PCR reactions were performed, one set using the Kpn Iforward primer and the Pst I-reverse primer, the second set using the Pst I-forward primer and the EcoR I-reverse primer, and the third set using the EcoR I-forward primer and the Mlu I-reverse primer. The products were digested and ligated into the reporter plasmid. The sequences of all constructs were verified using the resources of the Applied Genomics Technology Center at Wayne State University.
This article has not been copyedited and formatted. The final version may differ from this version. (Kocarek and Mercer-Haines, 2002 ) was used as a positive control.
After 5 hr incubation, transfection medium was replaced with fresh, unsupplemented OptiMEM (i.e., serum-free). The following day, cultures were incubated with OptiMEM containing either 0.1% DMSO or 10 -4 M ciprofibrate, and were harvested 24 hr later for the measurement of firefly and Renilla luciferase activities using the Dual Luciferase Reporter Assay System (Promega) and a Dynex model MLX Luminometer.
EMSA. EMSA was applied to either HepG2 nuclear extracts, prepared using the NE-PER forward 5'-GGTGCTAGCGCTCAAGG-3' (-11,748 to -11,732 ) and reverse 5'-AGCCAAGAAACCGCAGTT-3' (-11,588 to -11,605) . PCR amplifications were performed for 33 to 36 cycles, and products were visualized on ethidium bromide-stained 2.5% agarose gels.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
To determine the relative roles of liver-enriched nuclear receptor transcription factors in the regulation of (HUMAN)SULT2A1 gene transcription, primary cultured human hepatocytes were treated with a panel of known nuclear receptor activating agents (Fig. 1A) . Consistent with our previous findings (Duanmu et al., 2002) , induction of (HUMAN)SULT2A1 mRNA content occurred following treatment with a PXR-activating concentration of rifampin (Fig. 1A ).
Treatment with a PPARα-activating concentration of ciprofibrate (10 -4 M) also substantially increased (HUMAN)SULT2A1 mRNA content, by ~2-fold, relative to DMSO-treated control (Fig. 1A) . Treatment of human hepatocytes with ciprofibrate or Wy14643 (10 -4 M), another peroxisome proliferating drug, also induced the amounts of (HUMAN)SULT2A1 immunoreactive protein ( Fig. 1B ) and enzymatic activity (Fig. 1C) . By contrast, test activators of the FXR (chenodeoxycholic acid), liver X receptor [ 24(S),25-epoxycholesterol] or constitutive androstane receptor (phenobarbital) nuclear receptors failed to produce appreciable changes in hepatocellular (HUMAN)SULT2A1 mRNA content (Fig. 1A) . As previously demonstrated (Runge- Morris et al., 1999) , expression of the rat counterparts to (HUMAN)SULT2A1 was induced in primary cultured rat hepatocytes following treatment with a PXR-activating concentration of dexamethasone (Fig.   1D ). However, although ciprofibrate and Wy14643 treatments markedly increased the levels of CYP4A mRNA, a known PPARα target in the rat, these treatments failed to produce detectable increases in SULT2A mRNA content (Fig. 1D ).
This article has not been copyedited and formatted. The final version may differ from this version. The mechanism underlying ciprofibrate-inducible regulation of the (HUMAN)SULT2A1 gene was evaluated by performing transient transfection studies in HepG2 cells with a series of luciferase reporter plasmids, which contained progressively more upstream ~one kb regions ligated in cis with the first 492 nt of the (HUMAN)SULT2A1 promoter ( Fig. 2A) . As a reference parameter for these studies, a PPARα-responsive rat CYP4A1 luciferase reporter plasmid was used as a positive control. For these studies, the HepG2 cells were co-transfected with a PPARα expression plasmid. Following transfection, the cells were treated for 24 hr with DMSO or 10 -4 M ciprofibrate. As shown in Fig. 2A , ciprofibrate treatment caused an ~1.7-fold increase in CYP4A1-PPRE-driven luciferase expression, relative to DMSO-treated control. A similar ciprofibrate-mediated increase in reporter activity (~2.0-fold) was observed for cells transfected with the construct containing nt -6832 to -5812 (-6832:5812) of the (HUMAN)SULT2A1 5'-flanking region ( Fig. 2A) , suggesting that this portion of the (HUMAN)SULT2A1 5'-flanking region may harbor a functional PPRE. A ciprofibrate-mediated increase in luciferase activity (~1.7-fold) was also demonstrated for the -7626:6626 fragment ( Fig. 2A) . We also noted that cells transfected with plasmids containing these ciprofibrate-responsive regions had higher basal luciferase activities (i.e., DMSO-treated activities) than did those transfected with reporters that did not display ciprofibrate responsiveness. Additional experiments confirmed that transfection of HepG2 cells with the PPARα expression plasmid alone (without ciprofibrate treatment) was sufficient to produce some increase in reporter activity in ciprofibrate-responsive transfectants (data not shown). Such an effect has been documented previously (Barrero et al., 2003) .
This article has not been copyedited and formatted. The final version may differ from this version. Since our initial transfection studies primarily implicated information contained within the -6832:5812 fragment as responsible for mediating ciprofibrate-inducible expression, but secondarily suggested some involvement by sequences located within the -7626:6626 fragment, subsequent studies were focused on the entire -7624:5817 region (Fig. 2B) . Also, we noted that an additional construct designed to contain the overlap region between constructs -5825:4807 and -6832:5812 (construct -6042:5542) displayed elevated activity following transfection with PPARα, which was further enhanced by ciprofibrate treatment (Fig. 2B ). These findings suggested that the region common to constructs -6832:5812 and -6042:5542 (indicated by dotted lines) likely contained a ciprofibrate-responsive element. Systematic deletion of the overlap region from the -7624:5817 construct indicated that a marked loss of luciferase expression occurred when nt -5956 through -5905 were removed (Fig. 2B) . A computer-based analysis [MatInspector (Quandt et al., 1995) ] of the -5956:5905 region identified a sequence, at nt -5949 to -5929, with significant similarity (100% core; 83.3% overall) to the peroxisome proliferator responsive element matrix (V&PERO/PPARA.01). The sequence of this candidate (HUMAN)SULT2A1 PPRE (termed dPPRE for distal PPRE) differed from consensus by four nt, two of which were contained within the direct repeat of AGGTCA with one intervening nt (DR1) portion of the motif (Fig. 3A) .
Evaluation of the 492 nt proximal region of the (HUMAN)SULT2A1 promoter identified a second sequence, at -291 to -310, with significant similarity (100% core; 71.2% overall) to the PPRE matrix, although this sequence (termed pPPRE for proximal PPRE) contained four mismatches with the consensus PPRE within the DR1 region (Fig. 3A) . To evaluate the importance of the dPPRE in mediating ciprofibrate-inducible (HUMAN)SULT2A1 transcription, the effect of This article has not been copyedited and formatted. The final version may differ from this version. introducing a di-nucleotide mutation (AG6CT) into the core region of this element (in the downstream hexameric half-site of the DR1 motif) was evaluated in transient transfections. For comparison, a comparable mutation was introduced into the pPPRE. Also, both mutations were evaluated within the contexts of both the -6832:5812 fragment and the longer -7624:5817 fragment. As shown in Fig. 3B , mutation of the dPPRE largely abolished PPARα transfectionmediated luciferase expression, as well as the ciprofibrate-induced enhancement, within the contexts of both reporter constructs. By contrast, mutation of the pPPRE had no effect on ciprofibrate/PPARα-inducible reporter expression, and when introduced in combination with the dPPRE mutation, did not modify the suppression that was attributable to the dPPRE (Fig. 3B ),
indicating that the pPPRE is not a functional PPRE. To establish whether the (HUMAN)SULT2A1 dPPRE functions as an enhancer element, the effects of PPARα activation were examined in (HUMAN)SULT2A1 reporter plasmids containing either one, two or three concatemerized copies of the dPPRE (Fig. 3C) . The results demonstrated that increasing the copy number of the dPPRE in the (HUMAN)SULT2A1 promoter-luciferase reporter plasmid produced a dose-dependent increase in ciprofibrate/PPARα-inducible (HUMAN)SULT2A1 luciferase activity (Fig. 3C ).
As further support that the (HUMAN)SULT2A1 dPPRE represents a functional PPRE, EMSA analysis of HepG2 nuclear extracts demonstrated that the dPPRE competed for protein binding to a consensus PPRE probe, albeit with slightly less affinity than did the consensus competitor (Fig. 4A) . As expected, a dPPRE competitor containing the same di-nucleotide mutation that abolished ciprofibrate/PPARα responsiveness in the transfection assays, failed to This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4A) . These results were re-enforced by EMSA studies using in vitro transcribed/translated PPARα and RXR. Thus, the PPARα-RXR heterodimer bound directly to both the consensus PPRE probe and to a dPPRE probe, as indicated by the emergence of a more slowly migrating band, but not to the mutated dPPRE probe (Fig. 4B) . (Fig. 4C, antibody 2) . As seen for the HepG2 nuclear extract EMSAs, the (HUMAN)SULT2A1 dPPRE competed for the binding of consensus PPRE probe to in vitro transcribed/translated PPARα-RXR with slightly less affinity than did the consensus PPRE, while the mutant dPPRE did not compete at all (Fig. 4C ). Also consistent with our functional data, in vitro transcribed/translated PPARα-RXR did not bind to a probe corresponding to the pPPRE (data not shown).
To determine whether the dPPRE is a functional element within the context of the endogenous (HUMAN)SULT2A1 gene, a ChIP experiment was performed to investigate the association of that element with PPARα and RXR, as well as with PGC-1 and CBP, two coactivators that are expected to be associated with a functional PPRE following receptor activation (Mukherjee et al., 2002) . In this experiment, HepG2 cells were treated with DMSO or 10 -4 M ciprofibrate for either 24 hr (according to our treatment regimen in the transfection experiments), This article has not been copyedited and formatted. The final version may differ from this version. or for a shorter time, 2.5 hr, based on the knowledge that cofactor association can occur rapidly following ligand treatment, and is a highly dynamic process, in which complexes are continuously assembled and disassembled (Shang et al., 2000) . Immunoprecipitation with antibody directed against each of the aforementioned proteins, but not non-specific IgG, resulted in the amplification of a clear PCR product when primers flanking the dPPRE were used, but no product when primers targeting a further upstream region of the (HUMAN)SULT2A1 gene were employed (Fig. 5) . The
ChIP analysis indicated that PPARα and RXR were associated with the dPPRE in the absence or presence of ciprofibrate treatment, as would be expected for this heterodimeric transcription factor, which is known to be nuclear and associated with PPRE motifs independent of ligand treatment (Dowell et al., 1999) . Although these cultures were not transfected with supplemental PPARα, association was clearly evident, consistent with our ability to detect PPARα-RXR in untransfected HepG2 nuclear extracts by EMSA (Fig. 4A ). Ciprofibrate treatment, for either 2.5 hr or 24 hr, did not increase the amount of PPARα or RXR that was associated with the dPPRE. For the coactivators, treatment of HepG2 cells for 24 hr resulted in detectably greater association of CBP and PGC-1 with the dPPRE than was evident in the corresponding DMSO-treated controls, whereas such a difference was not evident in the 2.5 hr-treated cultures (Fig. 5) . These results indicate that the (HUMAN)SULT2A1 dPPRE serves as a functional response element within the context of the human genome.
Discussion
Relative to what is known about (RAT)SULT2A3 regulation, the molecular mechanisms that govern the expression of hepatic (HUMAN)SULT2A1 are less well defined. Transient transfection analyses suggest that the rat and human SULT2A genes share certain aspects of regulation in response to bile acid-sensitive nuclear receptor transcription factors. For example, in primary cultured rat hepatocytes, reporter constructs of both the rat and human SULT2A genes display inducible transcription following treatment with activators of PXR (Duanmu et al., 2002;  Runge- Morris et al., 1999) . Also, the loss of PXR expression in mice abolishes the inducible expression of mouse hepatic SULT2A following treatment with the PXR ligand, pregnenolone-16α-carbonitrile (Sonoda et al., 2002) . Similarly, transient co-transfection assays in HepG2 cells and 3T3 fibroblasts implicate a role for FXR in the transcriptional regulation of rat SULT2A (Song et al., 2001 ). The present study demonstrates that treatment of primary cultured human hepatocytes with a prototypical activator of PPARα (i.e., ciprofibrate or Wy14643) induces the mRNA and protein levels, as well as the enzymatic activity, of (HUMAN)SULT2A1. Subsequent transfection analyses demonstrated that a PPRE in the upstream (HUMAN)SULT2A1 5'-flanking region was responsible for PPARα-inducible (HUMAN)SULT2A1 gene transcription. In support of these findings, binding studies indicated that the PPARα-RXR heterodimer binds to the distal PPRE, although somewhat less avidly than to a consensus PPRE. By contrast, functional and EMSA analyses indicated that a more proximal sequence with significant similarity to a consensus PPRE in the (HUMAN)SULT2A1 5'-flanking region binds weakly, if at all, to PPARα.
This article has not been copyedited and formatted. The final version may differ from this version. In rodents, activation of PPARα produces peroxisome proliferation together with a cascade of cellular events, including excessive hydrogen peroxide generation, that ulitmately lead to hepatocarcinogenesis (Rao and Reddy, 1996) . In contrast, activation of PPARα in humans is not a potent inducer of peroxisome proliferation; nor is it a significant risk factor for the development of hepatocellular carcinoma (Frick et al., 1987) . Recent studies in A humanized@ transgenic mice that have been specifically engineered to express the human PPARα in liver have clearly demonstrated that both wild type and humanized PPARα mice respond similarly to treatment with PPARα activators, and demonstrate analogous increases in peroxisome proliferation and fatty acid metabolizing enzyme gene expression (Cheung et al., 2004) . However, unlike wild-type mice, PPARα humanized mice activate hepatocellular proliferation pathways with a markedly reduced efficiency, suggesting that the oxidant stress produced by peroxisome proliferators requires cell proliferation to tip the balance of events toward hepatocarcinogenesis (Cheung et al., 2004) .
Insights into the physiological function of human PPARα suggest that it plays a role in the regulation of compensatory insulin secretion in the pancreas and represents a central coordinator of hepatic lipid signaling in the liver (Sugden and Holness, 2004) . The induction of the bile acidconjugating enzyme, UGT2B4, by PPARα ligands in HepG2 cells was found to be transactivated through a PPRE located in the 5'-flanking region of the human UGT2B4 gene (Barbier et al., 2003) . Hepatic SULT2A1 enzyme activity is essential for the detoxication of deleterious bile acids, such as the hydrophobic bile acid, LCA, which is subject to conjugation by SULT2A1 (Staudinger et al., 2001) . Similarly, UGT2B4 and UGT2B7 in the human intestine efficiently catalyze the glucuronidation of hyodeoxycholic acid (Barbier et al., 2003; Strassburg et al., 2000) .
This article has not been copyedited and formatted. The final version may differ from this version. Given that both the UGT2B4 and (HUMAN)SULT2A1 enzymes are actively engaged as bile acid detoxicating enzymes in human liver and gastrointestinal tissues, it is reasonable to hypothesize that the genes that encode these enzymes share some common aspects of regulation.
There appears to be a dynamic exchange in communication that occurs between the regulatory matrices that control various branches of lipid metabolism. Bile acids, the end-products of cholesterol metabolism, represent natural ligands for the FXR transcription factor, which in turn regulates the expression of cholesterol and bile acid biosynthesis enzymes (Wang et al., 1999) .
The targeted disruption of FXR in mice produced elevations not only in bile acid concentrations, but also in cholesterol and triglyceride levels (Sinal et al., 2000) . The PPARα transcription factor potentiates fatty acid catabolism (Lee et al., 2003) , and in the liver where both the FXR and PPARα receptors are abundantly expressed, there is considerable opportunity for regulatory overlap. For example, deoxycholic acid induces the transcription of the human PPARα gene via an FXR-mediated mechanism (Torra et al., 2003) . In turn, the PPARα transcription factor mediates the transcriptional repression of cholesterol 7α-hydroxylase (CYP7A1) and sterol 27-hydroxylase (CYP27), key enzymes in bile acid biosynthesis (Post et al., 2001) . (RAT)SULT2A3 gene transcription has been shown to be inducible by the FXR in cell-based assays (Song et al., 2001) .
However, our present work in primary cultured human hepatocytes ( Fig. 1A ; lack of chenodeoxycholic acid-inducible expression) suggests that this mode of regulation by FXR may not be conserved in (HUMAN)SULT2A1.
A recent report on the effects of clofibric acid treatment on global gene expression in primary cultured rat, mouse and human hepatocytes, determined that the expression of the HNF1α
This article has not been copyedited and formatted. The final version may differ from this version. transcription factor was singularly increased in human but not rodent hepatocytes (Richert et al., 2003) . Although this suggests that certain genes in human hepatocytes may be regulated by peroxisome proliferator treatment through indirect effects on intermediary transcription factors, transient transfection, EMSA and ChIP analyses in the current study indicate that (HUMAN)SUTL2A1 is a direct target for regulation by the PPARα transcription factor in cultured human hepatocytes.
Our assessment of coactivator recruitment to the distal PPRE in SULT2A1 suggests that ligand-activated PPARα mediates SULT2A1 induction through a mechanism that includes the recruitment of CBP and PGC-1. Some association of both CBP and PGC-1 with the dPPRE was observed in untreated HepG2 cells. For PGC-1, this finding is consistent with a previous report that the in vitro binding of PGC-1 to PPARα occurs in a ligand-influenced manner, with some interaction occurring in the absence of ligand, which is then increased in the presence of ligand (Vega et al., 2000) . In addition, PGC-1, through its N-terminal region, has been reported to interact with the CBP/p300 coactivator (Wallberg et al., 2003) , providing a possible mechanism for the ligand-independent association of CBP with the dPPRE. a a a a c a a g a a c A A A G c t t 
